This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Elite Pharmaceuticals, Inc.
Drug Names(s): OxyNal, Oxycodone/naltrexone
Description: ELI-216 is an abuse-resistant oxycodone HCl. The drug is a combination of a narcotic agonist (oxycodone) in a sustained release formulation and an antagonist, naltrexone hydrochloride, formulated to deter abuse of the drug.
Additional information available to subscribers only: